Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I O Ellis

Showing results (81-90 of 346) with videos related to

Pageof 35
Sort By:
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 1, 1996
United Kingdom national audit of breast fine needle aspiration cytology in 1990-91--organization and level of activityC M Hunt, S Wilson, S E Pinder, et al.
Histopathology|November 20, 2008
Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanismsR A A Mohammed, I O Ellis, A H S Lee, et al.
British Journal of Cancer|January 1, 1997
Early-onset breast cancer--histopathological and prognostic considerationsJ Kollias, C W Elston, I O Ellis, et al.
British Journal of Clinical Practice. Supplement|November 1, 1989
DNA ploidy in fibroadenomas (abstract)A P Locker, B Dilks, I O Ellis, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 1, 1996
UK national audit of breast fine needle aspiration cytology in 1990-91: diagnostic criteriaC M Hunt, S Wilson, S E Pinder, et al.
British Journal of Cancer|September 1, 1992
P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapyA R Dixon, J Bell, I O Ellis, et al.
Journal of Clinical Pathology|March 3, 2009
Short- and long-term effects of a training session on pathologists' performance: the INQAT experience for histological grading in breast cancerA Paradiso, I O Ellis, F A Zito, et al.
BMJ (Clinical Research Ed.)|January 30, 1993
Use of tumour marker immunoreactivity to identify primary site of metastatic cancerA R Gamble, J A Bell, J E Ronan, et al.
Histopathology|January 4, 2008
Expression profiling technology: its contribution to our understanding of breast cancerE A Rakha, M E El-Sayed, J S Reis-Filho, et al.
The Journal of Pathology|August 5, 2003
Loss of CD59 expression in breast tumours correlates with poor survivalZ Madjd, S E Pinder, C Paish, et al.
Pageof 35

Showing results (81-90 of 346) with videos related to

Sort By:
Pageof 35
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 1, 1996
United Kingdom national audit of breast fine needle aspiration cytology in 1990-91--organization and level of activityC M Hunt, S Wilson, S E Pinder, et al.
Histopathology|November 20, 2008
Vascular invasion in breast cancer; an overview of recent prognostic developments and molecular pathophysiological mechanismsR A A Mohammed, I O Ellis, A H S Lee, et al.
British Journal of Cancer|January 1, 1997
Early-onset breast cancer--histopathological and prognostic considerationsJ Kollias, C W Elston, I O Ellis, et al.
British Journal of Clinical Practice. Supplement|November 1, 1989
DNA ploidy in fibroadenomas (abstract)A P Locker, B Dilks, I O Ellis, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|October 1, 1996
UK national audit of breast fine needle aspiration cytology in 1990-91: diagnostic criteriaC M Hunt, S Wilson, S E Pinder, et al.
British Journal of Cancer|September 1, 1992
P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapyA R Dixon, J Bell, I O Ellis, et al.
Journal of Clinical Pathology|March 3, 2009
Short- and long-term effects of a training session on pathologists' performance: the INQAT experience for histological grading in breast cancerA Paradiso, I O Ellis, F A Zito, et al.
BMJ (Clinical Research Ed.)|January 30, 1993
Use of tumour marker immunoreactivity to identify primary site of metastatic cancerA R Gamble, J A Bell, J E Ronan, et al.
Histopathology|January 4, 2008
Expression profiling technology: its contribution to our understanding of breast cancerE A Rakha, M E El-Sayed, J S Reis-Filho, et al.
The Journal of Pathology|August 5, 2003
Loss of CD59 expression in breast tumours correlates with poor survivalZ Madjd, S E Pinder, C Paish, et al.
Pageof 35